{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:20:37Z","timestamp":1790958037169,"version":"4.1.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Vortioxetine is approved for the treatment of Major Depressive Disorder\n(MDD). However, the safety of this drug in a large group of populations is still unclear. Thus, we\nhave tried to analyze the risk profile of vortioxetine.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Material and Methods:<\/jats:title>\n<jats:p>The data related to the risk profile of vortioxetine has been extracted from\nPub-Med from January 2014 to May 2019. The adverse drug reactions (ADRs) have been categorized\ninto listed and unlisted categories as per the Summary of product characteristics (SmPC) of\nthe innovator. Further, unlisted ADRs have been analyzed as per Naranjo Scale.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Galactorrhea, hyperprolactinemia, glycolimia, exacerbation of anxiety, weight gain, edema,\nexcessive itching, petechiae, and ecchymoses have been observed with the use of vortioxetine\nand falls under the unlisted category. Further, the causality assessment results have shown a probable\nrelation between vortioxetine and galactorrhea, hyperprolactinemia, edema, excessive itching,\necchymoses, and petechiae. Weight gain, glycolimia and exacerbation of anxiety have a possible relationship\nwith vortioxetine. The common ADRs observed with the use of vortioxetine are nausea,\ndiarrhea, constipation, vomiting, pruritus, including pruritus generalized, abnormal dreams, and\ndizziness.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> In conclusion, more data is required to establish a strong relationship between vortioxetine\nand reported unlisted ADRs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570159x18666200818195720","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T07:29:17Z","timestamp":1597822157000},"page":"711-717","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risks Associated with Vortioxetine in the Established Therapeutic Indication"],"prefix":"10.2174","volume":"19","author":[{"given":"Akansha","family":"Verma","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, National Institute of Pharmaceutical, Education and Research (NIPER), Raeberali, Lucknow (U.P.)- 226002,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, National Institute of Pharmaceutical, Education and Research (NIPER), Raeberali, Lucknow (U.P.)- 226002,India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X18666200818195720","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/185034\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X18666200818195720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T14:18:39Z","timestamp":1655389119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/185034\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x18666200818195720","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}